- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prosthetic Valve Malfunction in Poland
Total 667 results
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
University of FloridaPatient-Centered Outcomes Research InstituteActive, not recruitingProstate CancerUnited States
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Warner ChilcottCompletedBenign Prostatic HyperplasiaUnited States
-
dr. Laura C. G. de Graaff-HerderRecruitingDisorders of Sex Development | Congenital Adrenal Hyperplasia | Tuberous Sclerosis | Kallmann Syndrome | Prader-Willi Syndrome | Neurofibromatosis | Rett Syndrome | 22q11 Deletion Syndrome | Turner Syndrome | Noonan Syndrome | Allan-Herndon-Dudley Syndrome | Saethre-Chotzen Syndrome | Congenital Hypopituitarism | Cornelia... and other conditionsNetherlands
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
NCIC Clinical Trials GroupCompletedQuality of Life | Pain | Prostate CancerCanada
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Myrexis Inc.UnknownProstate CancerUnited States
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Bristol-Myers SquibbCompletedProstate CancerAustralia, United States, Chile, Spain, France, Italy, United Kingdom, Germany, Netherlands
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
DendreonTerminatedProstate CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science UniversityCompletedMalignant Solid Neoplasm | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Colorectal Carcinoma | Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate... and other conditionsUnited States
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe... and other collaboratorsActive, not recruitingProstate CancerSpain, Belgium, France, Italy, United Kingdom, Denmark, Canada, Ireland, Brazil, Norway, Poland, Switzerland
-
AgennixTerminatedProstate CancerUnited States
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
AbbottCompletedProstatic NeoplasmsCanada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
AbbottCompletedProstatic NeoplasmsUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
Candel Therapeutics, Inc.Active, not recruitingProstate CancerUnited States, Mexico
-
Active Biotech ABCompleted